Perceptive Advisors’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
GPP
KCM
BBA
WP
Perceptive Advisors's ABEO Position: Q2 2020 in Review
Perceptive Advisors sold out of Abeona Therapeutics (ABEO) in Q2 2020, closing a stake of 60,000 shares — an estimated $3.06M sold.
Perceptive Advisors first reported a position in ABEO in Q4 2014 and held it in 20 quarters. The position peaked at $14.2M in Q1 2018. 83 funds tracked by Wall St. Rank hold ABEO as of Q2 2020.
- Perceptive Advisors reported no remaining Abeona Therapeutics position as of Q2 2020 after selling out during the quarter.
- Perceptive Advisors sold 60,000 Abeona Therapeutics shares in Q2 2020, an estimated $3.06M.
- Perceptive Advisors first reported a position in Abeona Therapeutics in Q4 2014 and held it in 20 quarters.
- Perceptive Advisors's Abeona Therapeutics position peaked at $14.2M in Q1 2018.
- 83 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2020.
Based on Perceptive Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.